435 related articles for article (PubMed ID: 31455266)
1. Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs.
Yu J; Yu C; Feng B; Zhan X; Luo N; Yu X; Zhou Q
BMC Nephrol; 2019 Aug; 20(1):336. PubMed ID: 31455266
[TBL] [Abstract][Full Text] [Related]
2. Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease.
He K; Zhou X; Zhao J; Du H; Guo J; Deng R; Wang J
Biochem Genet; 2024 Feb; ():. PubMed ID: 38316653
[TBL] [Abstract][Full Text] [Related]
3. MiR-27b-3p inhibits the progression of renal fibrosis via suppressing STAT1.
Bai L; Lin Y; Xie J; Zhang Y; Wang H; Zheng D
Hum Cell; 2021 Mar; 34(2):383-393. PubMed ID: 33454903
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-4709-3p targets Large Tumor Suppressor Kinase 2 (LATS2) and induces obstructive renal fibrosis through Hippo signaling.
Jiang Z; Xia W; Dai G; Zhang B; Li Y; Chen X
Bioengineered; 2021 Dec; 12(2):12357-12371. PubMed ID: 34931960
[TBL] [Abstract][Full Text] [Related]
5. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
Ai K; Zhu X; Kang Y; Li H; Zhang L
Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
[TBL] [Abstract][Full Text] [Related]
6. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
[TBL] [Abstract][Full Text] [Related]
7. Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1-4 patients and their relationship with proteinuria and kidney function.
Donderski R; Szczepanek J; Naruszewicz N; Naruszewicz R; Tretyn A; Skoczylas-Makowska N; Tyloch J; Odrowąż-Sypniewska G; Manitius J
Int Urol Nephrol; 2022 Apr; 54(4):937-947. PubMed ID: 34312814
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease.
Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC
Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100
[TBL] [Abstract][Full Text] [Related]
9. circPlekha7 suppresses renal fibrosis via targeting miR-493-3p/KLF4.
Zhou W; Chen YX; Ke B; He JK; Zhu N; Zhang AF; Fang XD; Tu WP
Epigenomics; 2022 Feb; 14(4):199-217. PubMed ID: 35172608
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells.
Liu Y; Bi X; Xiong J; Han W; Xiao T; Xu X; Yang K; Liu C; Jiang W; He T; Yu Y; Li Y; Zhang J; Zhang B; Zhao J
Mol Ther; 2019 May; 27(5):1051-1065. PubMed ID: 30853453
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced activation of Twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis.
Liu M; Liu L; Bai M; Zhang L; Ma F; Yang X; Sun S
Biochem Biophys Res Commun; 2018 Jan; 495(3):2324-2330. PubMed ID: 29277613
[TBL] [Abstract][Full Text] [Related]
12. microRNA-206 overexpression inhibits epithelial-mesenchymal transition and glomerulosclerosis in rats with chronic kidney disease by inhibiting JAK/STAT signaling pathway.
Zhao SQ; Shen ZC; Gao BF; Han P
J Cell Biochem; 2019 Sep; 120(9):14604-14617. PubMed ID: 31148248
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
14. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
15. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
[TBL] [Abstract][Full Text] [Related]
16. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA myocardial infarction-associated transcript modulates the epithelial-mesenchymal transition in renal interstitial fibrosis.
Wang Z; Zhang B; Chen Z; He Y; Ru F; Liu P; Chen X
Life Sci; 2020 Jan; 241():117187. PubMed ID: 31863776
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of miRNAs in enterovirus 71-infected cells.
Xun M; Ma CF; Du QL; Ji YH; Xu JR
Virol J; 2015 Apr; 12():56. PubMed ID: 25889836
[TBL] [Abstract][Full Text] [Related]
19. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
[TBL] [Abstract][Full Text] [Related]
20. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
